Matches in Nanopublications for { ?s ?p "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_provenance.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_provenance.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_provenance.
- NP483488.RAZS64Oeds3D18KqILzkJpb2zlv1TWi5nVaTUu1SuI7SA130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483488.RAZS64Oeds3D18KqILzkJpb2zlv1TWi5nVaTUu1SuI7SA130_provenance.
- assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP763059.RAcU-Li01ey7bjT1vopahDxOvP_1nNaLmJcDE7SMSO5WE130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763059.RAcU-Li01ey7bjT1vopahDxOvP_1nNaLmJcDE7SMSO5WE130_provenance.
- NP763058.RAgovwBHoo1-DtxPmeGzyLq6o8BAMd0H4cvkHqqNVQp5Q130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763058.RAgovwBHoo1-DtxPmeGzyLq6o8BAMd0H4cvkHqqNVQp5Q130_provenance.
- NP483646.RA1aXH0ARrvqIIT9t-3IDDElBqTvOw0HDP_zbWt1mLLxw130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483646.RA1aXH0ARrvqIIT9t-3IDDElBqTvOw0HDP_zbWt1mLLxw130_provenance.
- NP763060.RAPcjzFYJC_aOPGnSjY0ZPiyts5-rh0PM3ykrrTqVb78c130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763060.RAPcjzFYJC_aOPGnSjY0ZPiyts5-rh0PM3ykrrTqVb78c130_provenance.